These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 30758239
21. Polymorphism of HLA-DR and HLA-DQ in rheumatoid arthritis patients and clinical response to methotrexate--a hospital-based study. Ali AA, Moatter T, Baig JA, Iqbal A, Hussain A, Iqbal MP. J Pak Med Assoc; 2006 Oct; 56(10):452-6. PubMed ID: 17144392 [Abstract] [Full Text] [Related]
22. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis. Drozdzik M, Rudas T, Pawlik A, Gornik W, Kurzawski M, Herczynska M. Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736 [Abstract] [Full Text] [Related]
24. Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis. Muralidharan N, Mariaselvam CM, Mithun CB, Negi VS. Clin Rheumatol; 2016 Apr; 35(4):879-85. PubMed ID: 25771854 [Abstract] [Full Text] [Related]
26. Analysis of association of ADORA2A and ADORA3 polymorphisms genotypes/haplotypes with efficacy and toxicity of methotrexate in patients with Rheumatoid arthritis. Grk M, Milic V, Dolzan V, Maksimovic N, Damnjanovic T, Pjevic MD, Pesic M, Novakovic I, Jekic B. Pharmacogenomics J; 2020 Dec; 20(6):784-791. PubMed ID: 32448869 [Abstract] [Full Text] [Related]
27. Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. Taraborelli M, Andreoli L, Archetti S, Ferrari M, Cattaneo R, Tincani A. Clin Exp Rheumatol; 2009 Dec; 27(3):499-502. PubMed ID: 19604445 [Abstract] [Full Text] [Related]
28. TGF-β1 +869C/T polymorphism increases susceptibility to rheumatoid arthritis in North Indian population. Patel SL, Prakash J, Gupta V. Clin Rheumatol; 2020 Oct; 39(10):2881-2888. PubMed ID: 32270333 [Abstract] [Full Text] [Related]
29. IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. Tolusso B, Pietrapertosa D, Morelli A, De Santis M, Gremese E, Farina G, Carniello SG, Del Frate M, Ferraccioli G. Pharmacogenomics; 2006 Jul; 7(5):683-95. PubMed ID: 16886894 [Abstract] [Full Text] [Related]
37. [Single nucleotide polymorphism of miR-149 and susceptibility of rheumatoid arthritis]. Xiao M, Ma Y, Chen X, Kuang B. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 May; 40(5):495-8. PubMed ID: 26032077 [Abstract] [Full Text] [Related]
38. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, Bertino JR. Proc Natl Acad Sci U S A; 2007 Aug 14; 104(33):13513-8. PubMed ID: 17686970 [Abstract] [Full Text] [Related]
40. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis. Berkun Y, Abou Atta I, Rubinow A, Orbach H, Levartovsky D, Aamar S, Arbel O, Dresner-Pollak R, Friedman G, Ben-Yehuda A. J Rheumatol; 2007 Aug 14; 34(8):1664-9. PubMed ID: 17611986 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]